What the french law says
"Biomedical research does not give rise to any direct or indirect financial compensation on the persons who lend themselves to it, apart from the reimbursement of the expenses incurred and, where applicable, the indemnity in compensation for the constraints suffered (...)".
​
Extract from Article L1121-11
of the Public Health Code
​
Expenses incurred:
Costs incurred during consultations carried out for research purposes, outside the scope of routine care, (transportation by ambulance, cab, or personal vehicle, accommodation costs, etc.). Although no text regulates these reimbursements, the Public Health Code provides that the patient is reimbursed for all the expenses.
​
Compensation:
Compensation defined in proportion to the time spent for the research to compensate for certain constraints linked to the protocol (hospitalization, painful acts necessary for research, etc.). For a given protocol, the compensation is the same for all participants and does not correspond to a salary or an honorarium. However, it is not mandatory. By ministerial decree of April 25, 2006, the maximum amount of compensation that a person may receive during the same year for his participation in biomedical research is € 4,500.
In France, the law of August 6, 2004 on the protection of individuals with regard to the processing of personal data prohibits the sponsor from having access to a patient's personal data. Therefore, in order to guarantee their security and the confidentiality of their data, promoters have no choice but to use a service provider company to make these reimbursements.
​
TrialPEX supports and tracks reimbursements for all types of patient expenses as part of their participation in your trial.